{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:02:32Z","timestamp":1776841352212,"version":"3.51.2"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ajogmf.2023.100974","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T06:13:05Z","timestamp":1681452785000},"page":"100974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Which first-trimester risk assessment method for preeclampsia is most suitable? A model\u2013based impact study"],"prefix":"10.1016","volume":"5","author":[{"given":"Lynn T.M.","family":"Strijbos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manouk L.E.","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salwan","family":"Al-Nasiry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc J.M.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubertina C.J.","family":"Scheepers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2023.100974_bib0001","doi-asserted-by":"crossref","first-page":"e12479","DOI":"10.1111\/mcn.12479","article-title":"Should women be advised to use calcium supplements during pregnancy? A decision analysis","volume":"14","author":"Meertens","year":"2018","journal-title":"Matern Child Nutr"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0002","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000512335","article-title":"Performance of the FMF first-trimester preeclampsia-screening algorithm in a high-risk population in the Netherlands","volume":"48","author":"Zwertbroek","year":"2021","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0003","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First trimester preeclampsia screening and prediction","volume":"226","author":"Chaemsaithong","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejogrb.2018.08.587","article-title":"Assessment of NICE and USPSTF guidelines for identifying women at high risk of pre-eclampsia for tailoring aspirin prophylaxis in pregnancy: an individual participant data meta-analysis","volume":"229","author":"Al-Rubaie","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0006","doi-asserted-by":"crossref","first-page":"e10066","DOI":"10.2196\/10066","article-title":"Implementation and effects of risk-dependent obstetric care in the Netherlands (expect Study II): protocol for an impact study","volume":"7","author":"van Montfort","year":"2018","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0007","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.preghy.2021.06.012","article-title":"Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent pre-term pre-eclampsia in Belgium","volume":"25","author":"Dubon Garcia","year":"2021","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0008","doi-asserted-by":"crossref","first-page":"e81959","DOI":"10.1371\/journal.pone.0081959","article-title":"Pre-eclampsia increases the risk of postpartum haemorrhage: a nationwide cohort study in the Netherlands","volume":"8","author":"von Schmidt auf Altenstadt","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0009","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/0272989X19889890","article-title":"Implementing a preeclampsia prediction model in obstetrics: cutoff determination and health care professionals\u2019 adherence","volume":"40","author":"van Montfort","year":"2020","journal-title":"Med Decis Making"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/uog.19076","article-title":"Cost-effectiveness of first-trimester screening with early preventative use of aspirin in women at high risk of early-onset pre-eclampsia","volume":"53","author":"Ortved","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta12060","article-title":"Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling","volume":"12","author":"Meads","year":"2008","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.02.036","article-title":"Impact on perinatal health and cost-effectiveness of risk-based care in obstetrics: a before-after study","volume":"223","author":"van Montfort","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022056","article-title":"Trial of feasibility and acceptability of routine low-dose aspirin versus early screening test indicated aspirin for pre-eclampsia prevention (TEST study): a multicentre randomised controlled trial","volume":"8","author":"Mone","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0014","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.midw.2015.06.012","article-title":"A cost-comparison of midwife-led compared with consultant-led maternity care in Ireland (the MidU study)","volume":"31","author":"Kenny","year":"2015","journal-title":"Midwifery"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0015","unstructured":"Zorginstituut Nederland. Aspirine Protect EC Tablet MSR 100mg. 2021. Available at:https:\/\/www.medicijnkosten.nl\/medicijn?artikel=ASPIRINE+PROTECT+EC+TABLET+MSR+100MG&id=5b0760c528dc974a3b3aa1a32b44682a. Accessed February 09, 2022."},{"key":"10.1016\/j.ajogmf.2023.100974_bib0016","unstructured":"Pharmacoeconomics National Centre of Pharmacoeconomics. Guidelines for inclusion of drug costs in pharmaeconomic evaluations. Version 1.16;1-9. Availabe at: https:\/\/www.ncpe.ie\/wp-content\/uploads\/2016\/09\/Final-Guidelines-for-Inclusion-of-Drug-Costs-in-Pharmacoeconomic-Evaluation-v1.16.pdf. Accessed February 09, 2022."},{"key":"10.1016\/j.ajogmf.2023.100974_bib0017","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/HYPERTENSIONAHA.118.11718","article-title":"Preeclampsia prevention using routine versus screening test-indicated aspirin in low-risk women","volume":"72","author":"Mone","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187477","article-title":"Update of the Dutch manual for costing studies in health care","volume":"12","author":"Kanters","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0019","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12913-018-3406-1","article-title":"Economic assessment of the use of the sFlt-1\/PlGF ratio test to predict preeclampsia in Germany","volume":"18","author":"Schlembach","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0020","unstructured":"Standaard Prijslijst Passantentarieven Gelre ziekenhuizen. Prestaties Medisch Specialistische Zorg, Overige Zorgproducten - Prestaties diagnostiek laboratoria. 2020. Available at:https:\/\/www.gelreziekenhuizen.nl\/wcm\/connect\/www\/715f5068-d1a3-42fe-b9a5-cbdff8ca1182\/Passantentarieven+2020%2C+Prestaties+diagnostiek+laboratoria.pdf?MOD=AJPERES&CVID=n9La84d. Accessed February 20, 2022."},{"key":"10.1016\/j.ajogmf.2023.100974_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.08.045","article-title":"Prevention of preeclampsia with aspirin","volume":"226","author":"Rolnik","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270490","article-title":"Cost-effectiveness analysis of implementing screening on preterm pre-eclampsia at first trimester of pregnancy in Germany and Switzerland","volume":"17","author":"Mewes","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ajogmf.2023.100974_bib0023","article-title":"Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence","volume":"4","author":"Olson","year":"2022","journal-title":"Am J Obstet Gynecol MFM"}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933323001167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933323001167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:52:43Z","timestamp":1762905163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933323001167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2589933323001167"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2023.100974","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Which first-trimester risk assessment method for preeclampsia is most suitable? A model\u2013based impact study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2023.100974","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100974"}}